CHD sped cognitive decline; choosing an antidiabetic for elderly patients
Jun 21, 2019•8 min•Ep. 56
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
This week's top stories in cardiology:
- Cognitive decline sped up after CHD
- Genetic analysis links PCSK9 inhibition and CV mortality
- Which antidiabetic for elderly patients? It depends on their CV risk
- Pivotal trial shows HFrEF benefits from baroreceptor stimulation
You can contact the Cardiocast by emailing us at podcasts@mdedge.com or you can interact with us on Twitter @MDedgeCardio
For the best experience, listen in Metacast app for iOS or Android